Cargando…
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
IMPORTANCE: Continuous assessment of the effectiveness and safety of the US Food and Drug Administration–authorized SARS-CoV-2 vaccines is critical to amplify transparency, build public trust, and ultimately improve overall health outcomes. OBJECTIVE: To evaluate the effectiveness of the Johnson &am...
Autores principales: | Corchado-Garcia, Juan, Zemmour, David, Hughes, Travis, Bandi, Hari, Cristea-Platon, Tudor, Lenehan, Patrick, Pawlowski, Colin, Bade, Sairam, O’Horo, John C., Gores, Gregory J., Williams, Amy W., Badley, Andrew D., Halamka, John, Virk, Abinash, Swift, Melanie D., Wagner, Tyler, Soundararajan, Venky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564583/ https://www.ncbi.nlm.nih.gov/pubmed/34726743 http://dx.doi.org/10.1001/jamanetworkopen.2021.32540 |
Ejemplares similares
-
Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
por: Pawlowski, Colin, et al.
Publicado: (2021) -
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
por: Pawlowski, Colin, et al.
Publicado: (2021) -
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
por: Puranik, Arjun, et al.
Publicado: (2021) -
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
por: Pawlowski, Colin, et al.
Publicado: (2021) -
Mapping each pre-existing condition’s association to short-term and long-term COVID-19 complications
por: Venkatakrishnan, A. J., et al.
Publicado: (2021)